Michael O'Connell, Chief Analytics Officer at Spotfire, on his journey to technology leadership in energy management ...

"Before receiving the implant, it was like having two black discs in my eyes, with the outside distorted," said Sheila Irvine ...

Most pharmaceuticals sold today have their origin in a biochemistry laboratory. Drug discovery has traditionally started with a biochemical pathway implicated in a pathophysiological process. An ...

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that results from an analysis of 160 real-world patients with ...

Figure 1: cDNA microarray analysis of DNA copy-number changes. Figure 3: Genome-wide mapping of DNA copy-number variation for breast cancer cell line BT474. Figure 4: High-resolution analysis of ...

About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...

China Medical University leads a multi-institution team reporting that MTAP deficiency suppresses cytosolic nucleic acid ...

AI translates electrical signals to the brain to help restore reading vision to treat a common form of blindness that was ...

Geographic atrophy, an advanced form of dry age-related macular degeneration, leaves almost five million people around the ...

Brisbane-based ObvioHealth has signed a three-year agreement with clinical-stage biotechnology company Vaxxas to support late-stage trials.

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that Dr. Sean Lyden, Dr. Joseph Campbell, and Dr. Peter ...

Having examined the options trading patterns of Illumina, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance Trading volume ...